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CRISPR/Cas9 advances engineering of microbial cell factories
One of the key drivers for successful metabolic engineering in microbes is the efficacy by which genomes can be edited.
As such there are many methods to choose from when aiming to modify genomes, especially those of model organisms
like yeast and bacteria. In recent years, clustered regularly interspaced palindromic repeats (CRISPR) and its associated
proteins (Cas) have become the method of choice for precision genome engineering in many organisms due to their
orthogonality, versatility and efficacy. Here we review the strategies adopted for implementation of RNA-guided
CRISPR/Cas9 genome editing with special emphasis on their application for metabolic engineering of yeast and bacteria.
Also, examples of how nuclease-deficient Cas9 has been applied for RNA-guided transcriptional regulation of target genes
will be reviewed, as well as tools available for computer-aided design of guide-RNAs will be highlighted. Finally, this
review will provide a perspective on the immediate challenges and opportunities foreseen by the use of CRISPR/Cas9
genome engineering and regulation in the context of metabolic engineering.
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